Targeting of a Bile Acid Receptor, Takeda G Protein Receptor 5 [TGR5], by a Novel First-in-Class Competitive Antagonist, SBI-364, Diminishes Hepatic and Renal Cystogenesis in Polycystic Liver and Kidney Disease
ACS Pharmacology & Translational Science | June 30, 2025 | Volume: 8 | Issue: 7 | Pages: 1950-1964
10.1021/acsptsci.4c00701
| PMID 40672683